Schedule III drug

Less US Cannabis Restrictions Could Ease Sector’s Fragmented Payments System
Less US Cannabis Restrictions Could Ease Sector’s Fragmented Payments System
August 30, 2023  |  Regulation

In a significant development for the cannabis industry, U.S. health officials have recommended easing restrictions on cannabis and reclassifying it as a Schedule III drug...

READ MORE >